In stage IV, non-small-cell lung cancer patients treated with cisplatin-based chemotherapy, ERCC1 protein expression did not predict response (Wachters et al, 2005), whereas ERCC1 mRNA expression was significantly associated with response (Cobo et al, 2007). The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.